Molecular Templates, Inc. (MTEM) Financial Statements (2024 and earlier)

Company Profile

Business Address 9301 AMBERGLEN BLVD
AUSTIN, TX 78729
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:61,000143,04493,885125,08497,95558,910
Cash and cash equivalents32,19024,98325,21885,45187,72158,910
Short-term investments 57,718118,06168,66739,63310,234 
Other undisclosed cash, cash equivalents, and short-term investments (28,908)     
Receivables   2347,508240 
Prepaid expense3,4593,9176,0802,3182,2441,485
Other current assets3,7901,2541,1254894,42419
Other undisclosed current assets 49  4,500  
Total current assets:68,298148,215101,324139,899104,86360,414
Noncurrent Assets
Operating lease, right-of-use asset11,1328,60811,1049,959
Property, plant and equipment14,63219,30922,25418,1586,8511,952
Long-term investments and receivables  8,986 1,510  
Long-term investments  8,986 1,510  
Other noncurrent assets3,4867,2445,1954,6761,8211,402
Other undisclosed noncurrent assets     26,62326,623
Total noncurrent assets:29,25044,14738,55334,30335,29529,977
TOTAL ASSETS:97,548192,362139,877174,202140,15890,391
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,32711,12714,92516,0096,1375,207
Accounts payable5041,6122,3501,4657802,517
Accrued liabilities8,8239,51512,57514,5445,3572,690
Deferred revenue45,57332,93714,01417,291
Debt     332,400
Deferred revenue and credits2,765
Other liabilities2,1822,6062,2112,50114170
Other undisclosed current liabilities   6,403 26,198 
Total current liabilities:57,08246,67037,55335,80132,50910,442
Noncurrent Liabilities
Long-term debt and lease obligation 36,16845,05527,13914,6223,2711,078
Long-term debt, excluding current maturities 36,16835,49114,9262,9403,2541,078
Capital lease obligations17 
Liabilities, other than long-term debt19,43034,9756,02820,7518191,582
Deferred revenue 5,90433,3504,53819,385
Other liabilities1,2951,6251,4901,366816628
Operating lease, liability12,2319,56412,21311,682
Derivative instruments and hedges, liabilities     3954
Other undisclosed noncurrent liabilities  9,817 2,653 
Total noncurrent liabilities:55,59880,03042,98435,3736,7432,660
Total liabilities:112,680126,70080,53771,17439,25213,102
Equity
Equity, attributable to parent(15,132)65,66259,340103,028100,90677,289
Common stock565650463727
Additional paid in capital429,646417,704328,314267,089195,573141,733
Accumulated other comprehensive income (loss)(66)(48)1718  
Accumulated deficit(444,768)(352,050)(269,041)(164,125)(94,704)(64,471)
Total equity:(15,132)65,66259,340103,028100,90677,289
TOTAL LIABILITIES AND EQUITY:97,548192,362139,877174,202140,15890,391

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues    22,27013,2853,395
Revenue, net987
Gross profit:    22,27013,2853,395
Operating expenses(108,625)(118,771)(119,687)(92,719)(44,284)(21,242)
Other undisclosed operating income19,75438,69718,845   
Operating loss:(88,871)(80,074)(100,842)(70,449)(30,999)(17,847)
Nonoperating income
(Investment Income, Nonoperating)
    3  
Interest and debt expense(121)(146)(1,237)(2)(115)(5,472)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(88,992)(80,220)(102,079)(70,448)(31,114)(23,319)
Other undisclosed loss from continuing operations before income taxes(3,673)(2,789)(2,832)   
Loss from continuing operations before income taxes:(92,665)(83,009)(104,911)(70,448)(31,114)(23,319)
Income tax expense(53) (5)   
Loss from continuing operations:(92,718)(83,009)(104,916)(70,448)(31,114)(23,319)
Loss before gain (loss) on sale of properties:(83,009)(104,916)(70,448)(31,114)(23,319)
Net loss:(92,718)(83,009)(104,916)(70,448)(31,114)(23,319)
Other undisclosed net income attributable to parent    1,027827179
Net loss attributable to parent:(92,718)(83,009)(104,916)(69,421)(30,287)(23,140)
Preferred stock dividends and other adjustments      (958)
Net loss available to common stockholders, diluted:(92,718)(83,009)(104,916)(69,421)(30,287)(24,098)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(92,718)(83,009)(104,916)(70,448)(31,114)(23,319)
Other comprehensive income (loss) (18)(65)(1)18  
Other undisclosed comprehensive loss      
Comprehensive loss:(92,736)(83,074)(104,917)(70,430)(31,114)(23,319)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   1,027827(779)
Comprehensive loss, net of tax, attributable to parent:(92,736)(83,074)(104,917)(69,403)(30,287)(24,098)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: